Physician profile
Darin Keith Winn
NPI 1437351723
$5,262.35
in general payments reported to CMS, 2019-2025
48 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $373 · 2021: $720 · 2022: $729 · 2023: $1,006 · 2024: $850 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,072.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $890.38 | 2020-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $636.84 | 2021-2025 | Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $503.95 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $376.74 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $299.94 | 2022-2025 | Evenity, Prolia, Repatha |
| Astellas Pharma US INC | $284.65 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $219.03 | 2020-2024 | Spravato, Xarelto |
| Dynavax Technologies Corporation | $191.06 | 2019-2025 | Heplisav-B |
| Abbott Laboratories | $165.53 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $160.82 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $128.05 | 2019-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Biohaven Pharmaceutical Holding Company LTD. | $115.10 | 2022 | |
| Phathom Pharmaceuticals, INC. | $99.24 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $96.92 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.15 | 2019-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darin Winn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.